DataMEDS AI, Inc.
MEDS
$1.00
$0.033.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -77.15% | -85.64% | -86.54% | -46.90% | 17,407.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -77.15% | -85.64% | -86.54% | -46.90% | 17,407.64% |
| Cost of Revenue | -78.07% | -86.34% | -14.65% | -46.01% | 15,367.30% |
| Gross Profit | -63.98% | -75.43% | -729.12% | -55.68% | 19,553.85% |
| SG&A Expenses | 37.81% | -81.34% | -4.82% | 1,622.26% | 812.22% |
| Depreciation & Amortization | -55.58% | -55.56% | 24.01% | 71.76% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.35% | -82.05% | -10.46% | 365.87% | 2,052.07% |
| Operating Income | -33.54% | 80.81% | -241.50% | -1,708.13% | -859.93% |
| Income Before Tax | -175.21% | 76.13% | -542.99% | -1,738.15% | -1,061.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -175.21% | 76.13% | -542.99% | -1,738.15% | -1,061.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -175.21% | 76.13% | -542.99% | -1,738.15% | -1,061.85% |
| EBIT | -33.54% | 80.81% | -241.50% | -1,708.13% | -859.93% |
| EBITDA | -48.77% | 81.47% | -286.90% | -2,283.00% | -729.09% |
| EPS Basic | -32.06% | 88.15% | -224.81% | -1,096.19% | -763.19% |
| Normalized Basic EPS | 34.12% | 87.78% | -59.35% | -1,048.98% | -763.32% |
| EPS Diluted | -32.06% | 88.15% | -224.81% | -1,096.19% | -763.19% |
| Normalized Diluted EPS | 34.12% | 87.78% | -59.35% | -1,048.98% | -763.32% |
| Average Basic Shares Outstanding | 108.41% | 101.52% | 97.95% | 53.66% | 34.58% |
| Average Diluted Shares Outstanding | 108.41% | 101.52% | 97.95% | 53.66% | 34.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |